Pain Diagnoses Seen for Most Patients With Cerebral Palsy

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 14, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 14, 2024 -- Most patients (89.0 percent) with cerebral palsy (CP) have one or more documented pain diagnoses, according to a research letter published online Aug. 5 in JAMA Neurology.

Mark D. Peterson, Ph.D., from the University of Michigan in Ann Arbor, and colleagues compared the prevalence of nociplastic, neuropathic, nociceptive, and mixed pain subtypes in adults with CP and examined their association with CP subtypes in a cohort study involving Medicare fee-for-service beneficiaries.

Data were included for 24,464 eligible adults with CP, of whom 89.0 and 11.0 percent had one or more documented pain diagnoses and no pain diagnosis, respectively; 15.2 percent had a single pain condition throughout the study, while 73.8 and 29.7 percent exhibited pain multimorbidity (at least two diagnoses) and pain extreme multimorbidity (at least five diagnoses), respectively. The researchers found that the distribution of patients by pain phenotype was 86.3, 45.8, and 16.9 percent with any evidence of nociceptive pain, any evidence of nociplastic pain, and any evidence of neuropathic pain, respectively. Across the cohort, the distribution of patients was 38.8, 30.8, 12.5, 4.1, 2.4, 0.2, and 0.1 percent with nociceptive pain only; nociceptive and nociplastic pain; neuropathic, nociceptive, and nociplastic pain; neuropathic and nociceptive pain; nociplastic pain only; neuropathic pain only; and neuropathic and nociplastic pain, respectively.

"Our finding of 89.0 percent pain prevalence underscores the importance of understanding and treating pain in adults with CP," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-15 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords